We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Research Alliance to Study Apoptosis

By Biotechdaily staff writers
Posted on 09 Oct 2003
A strategic research alliance to study programmed cell death has been announced by scientists at the University of Birmingham (UK) and Guava Technologies, Inc. More...
(Hayward, CA, USA).

Researchers in the department of chemical engineering at Birmingham will explore how Guava's benchtop microvolume cell analysis systems can accelerate the department's monitoring of cell cultures for apoptosis. The cell analysis systems, PCA and PCA-96, streamline cell analysis research by enabling scientists to perform a variety of whole cell assays at their bench-tops with less than a day of training. The Guava systems require only small numbers of cells in microliter sample volumes to produce highly accurate and easy-to-read results.

"The Guava PCA system will enable us to perform experiments that we could not easily accomplish with either manual microscopy or centralized flow cytometry systems,” said Professor Mohamed Al-Rubeai. "Our alliance with Guava Technologies will significantly increase both the speed and productivity for some of our key research programs in the field of apoptosis.”

Guava states that its products have broad applications in life sciences research, drug discovery, and biopharmaceutical production, but also offer potential for use in clinical testing and blood processing, as well as other areas where single cell analysis is important.





Related Links:
U. of Birmingham
Guava

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Immunofluorescence Analyzer
IFA System
New
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.